Anna Riccardi

Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies

Riccardo Riccardi, Daniela Meco, Tina Colombo et al. · Cancer Chemotherapy and Pharmacology · 2003 · 76 citations

Malignant Disease, Effective Combination, Medicine +6

Increased sensitivity to the platelet‐derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF‐BB‐mediated signaling and STI571‐induced Akt inactivation

Tiziana Servidei, Anna Riccardi, Maurizio Sanguinetti et al. · Journal of Cellular Physiology · 2006 · 52 citations

Tyrosine Kinase, Sti571‐induced Akt Inactivation, Receptor Inhibitor Sti571 +16

Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib

Tiziana Servidei, Anna Riccardi, Simona Mozzetti et al. · International Journal of Cancer · 2008 · 41 citations · Full text

Signaling Pathway, Glioma, Medicine +12

Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients

Anna Riccardi, Giorgio Mazzarella, Graziella Cefalo et al. · Cancer Chemotherapy and Pharmacology · 2003 · 39 citations

Medicine, Adult Patients, Pediatrics +4

Clinical pharmacokinetics of carboplatin in children

Riccardo Riccardi, Anna Riccardi, Anna Lasorella et al. · Cancer Chemotherapy and Pharmacology · 1994 · 29 citations

Medicine, Pediatrics, Pharmacotherapy +3